Peter Avery
Impact in
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
- Internal Medicine top 2%
Papers in
- Pharmacology 12
- Pharmacogenetics and Drug Metabolism 12
- Co-authors
- Farhad KamaliHilary WynnePatrick KestevenAnn K. DalyTayyaba KhanElizabeth SconcePeter WoodBarry P. King
- Journals
- British Journal of Haematology (4 papers)Journal of Experimental Biology (4 papers)Diabetologia (4 papers)Journal of the Royal Statistical Society Series C (Applied Statistics) (4 papers)Blood (3 papers)
- Partner nations
- United KingdomSouth AfricaNetherlands
In The Last Decade
Peter Avery
97 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Pharmacology 1.2k
- Internal Medicine 209
- Endocrinology, Diabetes and Metabolism 678
- Biochemistry 268
- Cardiology and Cardiovascular Medicine 791
Countries citing papers authored by Peter Avery
This map shows the geographic impact of Peter Avery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Avery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Avery more than expected).
Fields of papers citing papers by Peter Avery
This network shows the impact of papers produced by Peter Avery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Avery. The network helps show where Peter Avery may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Avery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 9 | |
| 2 | 2020 | 2 | |
| 3 | 2018 | 4 | |
| 4 | 2017 | 4 | |
| 5 | 2016 | 30 | |
| 6 | 2016 | 9 | |
| 7 | 2014 | 7 | |
| 8 | 2012 | 87 | |
| 9 | 2011 | 5 | |
| 10 | Vitamin D status in paediatric oncology patients compared to control subjects: grounds for targeted supplementation | 2010 | 1 |
| 11 | 2010 | 4 | |
| 12 | 2009 | 32 | |
| 13 | Argument-adjunct asymmetries in Ndebele: the long and the short of it | 2009 | 1 |
| 14 | 2009 | 16 | |
| 15 | 2008 | 22 | |
| 16 | 2008 | 5 | |
| 17 | 2006 | 26 | |
| 18 | Reduced beta cell function in offspring of mothers with young onset type 2 diabetes | 2005 | 3 |
| 19 | 2004 | 80 | |
| 20 | 1987 | 31 |
About Peter Avery
Peter Avery is a scholar working on Pharmacology, Internal Medicine, Animal Science and Zoology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, having authored 100 papers that have together received 3.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (12 papers), Hormonal Regulation and Hypertension (11 papers), Atrial Fibrillation Management and Outcomes (11 papers), Total Knee Arthroplasty Outcomes (9 papers), Orthopaedic implants and arthroplasty (9 papers), Orthopedic Infections and Treatments (7 papers), Blood Pressure and Hypertension Studies (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (6 papers). The work is most often cited by research in Pharmacology (1.2k citations), Internal Medicine (209 citations), Endocrinology, Diabetes and Metabolism (678 citations), Biochemistry (268 citations) and Cardiology and Cardiovascular Medicine (791 citations). Peter Avery has collaborated with scholars based in United Kingdom, South Africa and Netherlands. Frequent co-authors include Farhad Kamali, Hilary Wynne, Patrick Kesteven, Ann K. Daly, Tayyaba Khan, Elizabeth Sconce, Peter Wood, Barry P. King, J. H. Brackenbury and David J. Deehan. Their work appears in journals such as British Journal of Haematology, Journal of Experimental Biology, Diabetologia, Journal of the Royal Statistical Society Series C (Applied Statistics) and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.